Gregory J. Marszalek;Gregory D. Lundquist, Jr.;Sarah C. Slania;Karl J. Manske;Shri Niwas;Tushar A. Kshirsagar;Bryon A. Merrill;Joshua R. Wurst;Scott E. Langer;Kyle J. Lindstrom;Philip D. Heppner;Georg
发明人:
Tushar A. Kshirsagar,Bryon A. Merrill,Scott E. Langer,Kyle J. Lindstrom,Sarah C. Slania,Gregory J. Marszalek,Joshua R. Wurst,Karl J. Manske,Shri Niwas,Gregory D. Lundquist, Jr.,Philip D. Heppner,Georg
申请号：
US11884982
公开号：
US08846710B2
申请日:
2006.02.22
申请国别(地区):
US
年份:
2014
代理人:
摘要：
A method of preferentially inducing IFN-α biosynthesis in an animal comprising administering certain imidazo[4,5-c] ring compounds with a hydroxymethyl or hydroxyethyl substituent at the 2-position or pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of using these compounds a immunomodulators for treatment of diseases including viral and neoplastic diseases comprising preferentially inducing IFN-α biosynthesis in an animal are disclosed.
